secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenon Medical, Inc. (TNON)
CIK:        0001560293
Form:       8-K
Filed at:   2026-07-24T20:45:38+00:00
Accession:  0001213900-26-081438
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tenon Medical shareholders approve reverse stock split and debt financing issuance
--------------------------------------------------------------------------------

- All seven director nominees elected, including Richard Ferrari, Steven Foster, and others.
- Reverse stock split approved at ratio from 1:2 to 1:35; board to set final ratio.
- Issuance of shares for convertible notes (debt financing) approved; may exceed 19.99% of outstanding.
- Future financings proposal approved for any 20% issuance priced below minimum price.
- Ratification of Haskell & White LLP as auditor and adjournment proposal also approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560293/000121390026081438/0001213900-26-081438-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560293/000121390026081438/ea0299237-8k_tenon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-081438

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer